MarketWise Q2 Billings Surge 57% but Net Loss Widens; Cash Drops to $32.9M
MKTW sits 47% above its 52-week low of $13.49.
Summary
MarketWise's Q2 2026 billings jumped 57% to $91.2M, the highest since 2023, but heavy marketing spend drove a net loss of $2.6M and cash reserves fell to $32.9M.
Key Events · Earnings and Guidance · MKTW
-
Billings Surge 57%
Q2 2026 billings reached $91.2M, up 57% YoY and the highest since 2023, driven by successful product launches and increased marketing spend.
-
Net Loss Despite Revenue Growth
Net loss of $2.6M vs. $15.3M profit in Q2 2025, as sales and marketing expenses jumped 35% to $42.8M, outpacing a 5% revenue decline.
-
Cash Position Halved
Cash and equivalents fell to $32.9M from $70.1M at year-end 2025, reflecting $12.2M settlement payment to former CEO and $55.9M in financing outflows.
-
New $50M Buyback Authorized
Board authorized a new $50M share repurchase program on May 7, 2026, replacing the expired prior authorization; only $370K repurchased in H1 2026.
Analysis · MKTW · Technology
MarketWise delivered its strongest quarterly billings since 2023 — $91.2 million, up 57% year-over-year — driven by aggressive marketing that boosted paid subscribers for the first time in years. However, that spending pushed the company to a $2.6 million net loss, reversing a $15.3 million profit a year ago. Cash and equivalents fell to $32.9 million from $70.1 million at year-end, partly due to a $12.2 million settlement with the former CEO. A new $50 million buyback authorization signals confidence, but the cash burn and operating loss raise questions about sustainability if billings growth doesn't convert to profits.
At the time of this filing, MKTW was trading at $19.81 on NASDAQ in the Technology sector, with a market capitalization of approximately $341.3M. The 52-week trading range was $13.49 to $22.83. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.